M14TIL Trial: TIL Compared to Std. Ipilimumab [2022] Melanoma and Skin 6 Mins Read3 M14TIL Trial: TIL Compared to Std. Ipilimumab [2022] This is the first experiment to use tumor-infiltrating lymphocytes (TIL) in metastatic…
